T45.AX5 Catégorie · précision supplémentaire requise Adverse effect of immune checkpoint inhibitors and immunostimulant drugs

ICD-10-CM T45.AX5 identifies “Adverse effect of immune checkpoint inhibitors and immunostimulant drugs” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Chapitre 19: Injury, poisoning and certain other consequences of external causes

Instructions du code

Aucune note supplémentaire.

Instructions des niveaux supérieurs

Chapitres 19 · Injury, poisoning and certain other consequences of external causes (S00-T88)

Excludes 22
  • birth trauma (P10-P15)
  • obstetric trauma (O70-O71)
Use additional code1

code to identify any retained foreign body, if applicable (Z18.-)

Note2
  • Use secondary code(s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code
  • The chapter uses the S-section for coding different types of injuries related to single body regions and the T-section to cover injuries to unspecified body regions as well as poisoning and certain other consequences of external causes.

T36-T50 · Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances (T36-T50)

Includes4
  • adverse effect of correct substance properly administered
  • poisoning by overdose of substance
  • poisoning by wrong substance given or taken in error
  • underdosing by (inadvertently) (deliberately) taking less substance than prescribed or instructed
Excludes 11

toxic reaction to local anesthesia in pregnancy (O29.3-)

Excludes 25
  • abuse and dependence of psychoactive substances (F10-F19)
  • abuse of non-dependence-producing substances (F55.-)
  • immunodeficiency due to drugs (D84.821)
  • drug reaction and poisoning affecting newborn (P00-P96)
  • pathological drug intoxication (inebriation) (F10-F19)
Code first7
  • , for adverse effects, the nature of the adverse effect, such as:
  • adverse effect NOS (T88.7)
  • aspirin gastritis (K29.-)
  • blood disorders (D56-D76)
  • contact dermatitis (L23-L25)
  • dermatitis due to substances taken internally (L27.-)
  • nephropathy (N14.0-N14.2)
Use additional code4
  • code(s) to specify:
  • manifestations of poisoning
  • underdosing or failure in dosage during medical and surgical care (Y63.6, Y63.8-Y63.9)
  • underdosing of medication regimen (Z91.12-, Z91.13-)
Note1

The drug giving rise to the adverse effect should be identified by use of codes from categories T36-T50 with fifth or sixth character 5.

T45 · Poisoning by, adverse effect of and underdosing of primarily systemic and hematological agents, not elsewhere classified

Seventh character1

The appropriate 7th character is to be added to each code from category T45

A — initial encounter

D — subsequent encounter

S — sequela

T45.A · Poisoning by, adverse effect of and underdosing of immune checkpoint inhibitors and immunostimulant drugs

Excludes 11

poisoning by, adverse effect of and underdosing of antineoplastic and immunosuppressive drug (T45.1)

Codes plus précis

Références de l’index officiel

Références de l’index officiel (2)

Immune (1)
Immunostimulant drug (1)
Références depuis d’autres codes (2)
Historique

Historique du code

Dernière modification enregistrée · FY2025 · 04-01

ModifiéInchangé
FY2025 · 04-01

En vigueur dès le

  • Instructions héritées modifiées

Adverse effect of immune checkpoint inhibitors and immunostimulant drugs

Catégorie — choisir un code plus précis

CDC/NCHS · FY2025 · 04-01

Toutes les éditions (5)

Toutes les éditionsEn vigueur dès leHistorique du code
FY20252024-10-01Ajouté
FY2025 · 04-012025-04-01Instructions héritées modifiées
FY20262025-10-01Aucun changement tabulaire
FY2026 · April2026-04-01Aucun changement tabulaire
FY20272026-10-01Aucun changement tabulaire

Explorez les codes plus précis de cette catégorie. La vérification du référentiel ne confirme pas la pertinence clinique et ne garantit pas le remboursement.